Skip to main content
. 2016 Dec 13;12(12):e1006104. doi: 10.1371/journal.ppat.1006104

Fig 1. Timeline and outcome of the longitudinal vaccine study.

Fig 1

(A) A schematic diagram demonstrating 18 animals were vaccinated with SIVΔnef and intra-vaginally challenged at week 5, week 20 or week 40 with SIVmac251. Three control animals were inoculated with SIVmac251 with each vaccination group. (B) Plasma viremia of control and SIVΔnef-vaccinated animals after vaginal challenge with SIVmac251.